Amylyx (AMLX) downgraded to Buy after AMX0035 PSP halt; focus shifts to avexitide Phase 3 with Q3 2026 data and strong cash ...
More than 80% of patients implanted with a transvenous phrenic nerve stimulation device for central sleep apnea had at least ...
Discover the impact of digital pathology on drug discovery and biomarker research this International Women’s Day with Dr ...
The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular ...
Background: The factors involved in the association between obstetric trauma and the race of the birthing parent are ...
EMP-01 met its primary objective on safety and tolerability, demonstrating a generally favorable and manageable safety and tolerability profileEMP-01 demonstrated a clinically meaningful placebo-adjus ...
MedPage Today on MSN
What's the Top Priority for Older Adults With Advanced Cancer?
Study finds that 8% prioritized extending life, while 72% prioritized maintaining QoL ...
Held Type A meeting with FDA to discuss AMT-130 for Huntington’s disease; Company evaluating Phase III development considerations and plans to ...
From national parks to wilderness areas, these 10 iconic American landscapes face new threats. See which places are most at ...
The global wine industry spent two years in crisis. New data on drinking habits, a landmark EU trade deal, and hard-won ...
11d
Tanabe Pharma America to Highlight Research in ALS at 2026 MDA Clinical and Scientific Conference
Tanabe Pharma America, Inc. (TPA) today announced two poster presentations showcasing research in amyotrophic lateral sclerosis (ALS) at the 2026 Muscular Dystrophy Association (MDA) Clinical & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results